Paradromics

Medical Devices & EquipmentSeries AAustin, USparadromics.com

Latest round

Series A

Last raised

May 2023

Total raised

$61M

Investors

11

About Paradromics

Based in Texas, US, Paradromics, Inc.Paradromics, Inc. specializes in developing innovative neurotechnology solutions.Paradromics specializes in advanced neurotechnology, with a focus on its flagship product, the Connexus® Brain-Computer Interface (BCI). This innovative platform records brain activity at the individual neuron level, utilizing AI algorithms to decode extensive brain data, facilitating the translation of thoughts into actionable treatments. The primary end use cases for this technology include assisting individuals suffering from conditions such as paralysis, movement disorders, chronic pain, addiction, and mental health issues like depression. The Connexus® BCI aims to empower those unable to communicate due to ALS, spinal cord injuries, and strokes, allowing them to interact with digital devices independently.Paradromics' revenue structure is primarily rooted in the commercialization of its proprietary BCI technology, particularly the Connexus® BCI. The company engages in direct-to-consumer transactions, focusing on patients and caregivers who seek innovative solutions for severe communication impairments. The revenue model encompasses partnerships with healthcare institutions, research organizations, and possibly subscription-based services for ongoing support and software updates. The transactional dynamics revolve around the sale or distribution of the Connexus® BCI and associated services, tailored to the specific medical and therapeutic needs of the client base. As the technology is still in the investigational phase, pricing for these products and services is not publicly defined but is expected to align with industry standards for advanced medical devices. In December 2025, Paradromics, Inc.

Who invested in Paradromics

11 investors across 4 rounds

See all investors in Paradromics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    May 18, 2023

    Amount

    $33M

    Investors

    Locked

  2. Seed

    Jul 22, 2021

    Amount

    $20M

    Investors

    Locked

  3. Seed

    Jun 11, 2018

    Amount

    $7M

    Investors

    Locked

  4. Seed

    May 17, 2018

    Amount

    $0.9M

    Investors

    Locked

Questions about Paradromics

Who invested in Paradromics?

Paradromics has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Paradromics raised?

Paradromics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did Paradromics last raise money?

Paradromics's most recent round on record is a Series A, in May 2023.

What does Paradromics do?

Based in Texas, US, Paradromics, Inc.

Where is Paradromics headquartered?

Paradromics is headquartered in Austin, US.

Which VCs invest in companies like Paradromics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Paradromics's stage. Their profiles are linked below.

Raising like Paradromics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.